Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.33%138.060.0%$905.80m
AMGNAmgen, Inc. 1.07%250.151.5%$837.83m
GILDGilead Sciences, Inc. 0.53%64.181.0%$544.89m
VRTXVertex Pharmaceuticals, Inc. 4.33%269.781.9%$481.94m
REGNRegeneron Pharmaceuticals, Inc. 3.63%685.152.6%$437.43m
ILMNIllumina, Inc. 1.01%245.943.3%$316.96m
NVAXNovavax, Inc. -1.20%52.7875.7%$303.82m
BIIBBiogen, Inc. 0.46%200.561.8%$241.14m
BNTXBioNTech SE 0.40%163.650.0%$227.31m
SNSSSunesis Pharmaceuticals, Inc. -0.47%2.100.7%$146.80m
EXASEXACT Sciences Corp. -2.14%52.0317.7%$143.93m
NKTXNkarta, Inc. 0.67%12.760.0%$99.97m
BMRNBioMarin Pharmaceutical, Inc. 1.38%80.824.2%$99.76m
TECHBio-Techne Corp. -1.03%362.574.5%$99.76m
TXG10X Genomics, Inc. -1.60%49.360.0%$99.67m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987, and is headquartered in Foster City, CA.